Database Registry for Neural Network Biomarkers in Psychosis
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT01409109
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Study Details
Several observations have been made with magnetic resonance imaging (MRI) that characterize brain connections and brain function in individuals with schizophrenia and other mental disorders. For example, research investigating schizophrenia focuses on the dysfunction of connections within and between the medial temporal lobe and the prefrontal cortex as well as other pertinent brain regions. This database registry will allow for the collection of clinical interview data, behavioral data, blood, magnetic resonance imaging (MRI) data, and functional magnetic resonance imaging (fMRI) data on individuals with and without mental disorders to better understand how connections in the brain and various brain regions function differently while volunteers perform various cognitive tasks. This is an observational study that is being conducted to collect data and place it in a registry for current and future investigational questions related to imaging in mental disorders.
Key Dates
- Start date
- Mar 31, 2010
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2029
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Patient volunteersThis group is comprised of persons with Schizophrenia and Schizoaffective.
- Arm: Healthy volunteersThis group is comprised of individuals who have no current or past psychiatric diagnosis.
Primary Outcome Measure
Differences in hippocampal subfield activation between people with schizophrenia (or schizoaffective disorder) and healthy volunteers [ Time Frame: Participants will be assessed over the course of 4-6 weeks, until all study procedures are complete ]
Central Contacts
- Elena Ivleva, M.D., Ph.D.214-645-8942
- Debra Bushong, M.S., L.P.C.214-648-4653
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Carol A. Tamminga, M.D. (PRINCIPAL_INVESTIGATOR) Elena Ivleva, M.D., Ph.D. (SUB_INVESTIGATOR) |
Find similar trials in Dallas, TX
Related Studies
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaPHASE3 · Recruiting · Gedeon Richter Plc. · Culver City, California
- Ocrelizumab for Psychosis by AutoimmunityPHASE1/PHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas
- CLOZAPINE Response in Biotype-1PHASE4 · Recruiting · University of Texas Southwestern Medical Center · Hartford, Connecticut
- Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar DisorderPHASE1 · Recruiting · BioXcel Therapeutics Inc · Anaheim, California